A detailed history of Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group holds 85,000 shares of CCCC stock, worth $513,400. This represents 0.21% of its overall portfolio holdings.

Number of Shares
85,000
Previous 85,000 -0.0%
Holding current value
$513,400
Previous $393 Million 23.38%
% of portfolio
0.21%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 20, 2024

BUY
$1.18 - $6.03 $100,300 - $512,550
85,000 New
85,000 $480 Million
Q4 2021

Aug 22, 2024

SELL
$29.39 - $46.86 $1.18 Million - $1.87 Million
-40,000 Reduced 47.06%
45,000 $1.45 Billion

Others Institutions Holding CCCC

About C4 Therapeutics, Inc.


  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $295M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Portfolio

Follow Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group, based on Form 13F filings with the SEC.

News

Stay updated on Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group with notifications on news.